From Papanicolaou to Papillomaviruses: Evolving Challenges in Cervical Cancer Screening in the Era of Human Papillomavirus Vaccination

Por Safaeian, Mahboobeh, Sherman, Mark E.
Publicado em 2013

Traceback: leveraging archived biospecimens to identify mutation carriers

Por Samimi, Goli, Sherman, Mark E.
Publicado no Oncotarget (2017)

Human Papillomavirus Vaccines for Cervical Cancer Prevention: Translating Possibility Into Reality

Por Sahasrabuddhe, Vikrant V., Sherman, Mark E.
Publicado em 2012

Computational disease progression modeling can provide insights into cancer evolution

Por Goodison, Steve, Sherman, Mark E., Sun, Yijun
Publicado no Oncoscience (2020)

Qualitative Age Interactions in Breast Cancer Studies: Mind the Gap

Por Anderson, William F., Jatoi, Ismail, Sherman, Mark E.
Publicado em 2009

Opportunities for Molecular Epidemiological Research on Ductal Carcinoma In-situ and Breast Carcinogenesis: Interdisciplinary Approaches

Por Sherman, Mark E., Mies, Carolyn, Gierach, Gretchen L.
Publicado no Breast Dis (2014)

Utility of Methylation Markers in Cervical Cancer Early Detection: Appraisal of the State-of-the-Science

Por Wentzensen, Nicolas, Sherman, Mark E., Schiffman, Mark, Wang, Sophia S.
Publicado em 2008

Lobular Involution, Mammographic Density, and Breast Cancer Risk: Visualizing the Future?

Por Gierach, Gretchen L., Brinton, Louise A., Sherman, Mark E.
Publicado em 2010

Progesterone and Breast Cancer

Por Trabert, Britton, Sherman, Mark E, Kannan, Nagarajan, Stanczyk, Frank Z
Publicado no Endocr Rev (2019)

The Case for Conducting a Randomized Clinical Trial to Assess the Efficacy of a Single Dose of Prophylactic HPV Vaccines Among Adolescents

Por Kreimer, Aimée R., Sherman, Mark E., Sahasrabuddhe, Vikrant V., Safaeian, Mahboobeh
Publicado no J Natl Cancer Inst (2015)

Recent Trends in Breast Cancer Among Younger Women in the United States

Por Brinton, Louise A., Sherman, Mark E., Carreon, J. Daniel, Anderson, William F.
Publicado em 2008

Analysis of Serial Ovarian Volume Measurements and Incidence of Ovarian Cancer: Implications for Pathogenesis

Por Bodelon, Clara, Pfeiffer, Ruth M., Buys, Saundra S., Black, Amanda, Sherman, Mark E.
Publicado em 2014

Emerging Concepts in Breast Cancer Risk Prediction

Por Gierach, Gretchen L., Yang, Xiaohong R., Figueroa, Jonine D., Sherman, Mark E.
Publicado no Curr Obstet Gynecol Rep (2013)

Using ultrasound tomography to identify the distributions of density throughout the breast

Por Sak, Mark, Duric, Neb, Littrup, Peter, Sherman, Mark E., Gierach, Gretchen L.
Publicado no Proc SPIE Int Soc Opt Eng (2016)

How Many Etiological Subtypes of Breast Cancer: Two, Three, Four, Or More?

Por Anderson, William F., Rosenberg, Philip S., Prat, Aleix, Perou, Charles M., Sherman, Mark E.
Publicado em 2014

Response

Por Anderson, William F., Rosenberg, Philip S., Prat,, Aleix, Perou, Charles M., Sherman, Mark E.
Publicado no J Natl Cancer Inst (2015)

The Surveillance, Epidemiology and End Results (SEER) Program and Pathology: Towards Strengthening the Critical Relationship

Por Duggan, Máire A., Anderson, William F., Altekruse, Sean, Penberthy, Lynne, Sherman, Mark E.
Publicado no Am J Surg Pathol (2016)

Population Frequency of Serous Tubal Intraepithelial Carcinoma (STIC) in Clinical Practice Using SEE-Fim Protocol

Por Samimi, Goli, Trabert, Britton, Geczik, Ashley M, Duggan, Máire A, Sherman, Mark E
Publicado no JNCI Cancer Spectr (2018)

Molecular Pathology in Epidemiological Studies: A Primer on Key Considerations

Por Sherman, Mark E., Howatt, Will, Blows, Fiona M., Pharoah, Paul, Hewitt, Stephen M., Garcia-Closas, Montserrat
Publicado em 2010

Recent Changes in Endometrial Cancer Trends Among Menopausal-Age US Women

Por Wartko, Paige, Sherman, Mark E, Yang, Hannah P, Felix, Ashley S, Brinton, Louise A, Trabert, Britton
Publicado em 2013